Revvity and element biosciences announce collaboration to improve next generation sequencing research workflow

Waltham, mass. & san diego--(business wire)--revvity, inc. and element biosciences, inc., a developer of the aviti™ system, an innovative and emerging genomic sequencing platform, today announced a collaboration to introduce workflow solutions that save time and effort required for genomic analysis of samples. “this collaboration between revvity and element biosciences seeks to elevate the overall customer experience by providing compelling application-specific data, stronger support and easier.
RVTY Ratings Summary
RVTY Quant Ranking